BioCardia to Host Q1 2026 Financial Results and Corporate Update Conference Call on May 15, 2026
BioCardia, Inc., a developer of cellular therapeutics for cardiovascular and pulmonary diseases, announced it will report its Q1 2026 financial results and provide a corporate update via conference call and webcast on May 15, 2026. The call will include management remarks followed by a Q&A session, allowing stakeholders to get the latest insights o…